Raymond James Financial Inc Relay Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 189,046 shares of RLAY stock, worth $852,597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,046Holding current value
$852,597% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
203Shares Held
156MCall Options Held
192KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$126 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$65.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$47.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$41.7 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$33.3 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $542M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...